Release Date: 06/10/10 14:33 Summary: 2010 Annual General Meeting Price Sensitive: No Download Document 76.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%